Clal Biotechnology reported ILS-6166000 in Net Income for its fiscal quarter ending in December of 2022.


Net Income Change Date
Clal Biotechnology ILS -6166000 15.56M Dec/2022
Compugen USD -7340000 1.22M Jun/2025
Life Technologies USD -19530000 4.56M Jun/2025
RedHill Biopharma USD -1540000 0 Jun/2024